NSAID-exacerbated respiratory disease, dupilumab and aspirin tolerance
European Respiratory Journal · 2023
DOI: 10.1183/13993003.02467-2022 ↗Kurz gefasst
Editorial in der Zeitschrift European Respiratory Journal, 2023. Verfasst von Donald W Cockcroft. Beteiligte Einrichtung: Respiratory Medicine, Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK, C…. Hauptthemen laut MEDLINE: Respiration Disorders, Respiratory Tract Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Respiratory Medicine, Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada don.cockcroft@usask.ca.
Zitieren
APA
Cockcroft, D. W. (2023). NSAID-exacerbated respiratory disease, dupilumab and aspirin tolerance. European Respiratory Journal. https://doi.org/10.1183/13993003.02467-2022
Vancouver
Cockcroft DW. NSAID-exacerbated respiratory disease, dupilumab and aspirin tolerance. European Respiratory Journal. 2023. doi:10.1183/13993003.02467-2022
BibTeX
@article{Cockcroft2023,
author = {Cockcroft, Donald W},
title = {NSAID-exacerbated respiratory disease, dupilumab and aspirin tolerance},
journal = {European Respiratory Journal},
year = {2023},
doi = {10.1183/13993003.02467-2022}
}
EUVIMED